verapamil has been researched along with Bright Disease in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Monotherapy with calcium antagonists nifedipine, foridon and verapamil hydrochloride was assessed in 46 patients with chronic glomerulonephritis and arterial hypertension by hypotensive effect and changes in systemic and renal hemodynamics, water-electrolytic balance, renin-angiotensin system." | 5.06 | [Calcium antagonists in the treatment of nephrogenic hypertension]. ( Galstian, GM; Kutyrina, IM; Rogov, VA; Tareeva, IE, 1990) |
| "Following multiple myocardial infarctions, a patient was treated with the calcium channel-blocking agent nifedipine." | 3.67 | Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine. ( Hall-Craggs, M; Light, PD; Peters, RW, 1984) |
| "The effect of long-term treatment with either enalapril or high dose verapamil on survival, proteinuria, blood pressure and renal morphology was studied in female Wistar rats with markedly reduced renal mass." | 3.67 | Long-term enalapril and verapamil in rats with reduced renal mass. ( Bock, HA; Brunner, FP; Hermle, M; Mihatsch, MJ; Thiel, G, 1989) |
| "Hypertension is a potentially life-threatening condition that can lead to heart failure, stroke, and kidney disease." | 2.39 | Management of the hypertensive patient: a case report. ( Barry, JM; Bolt, TR; Smith, CJ, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cove-Smith, A | 1 |
| Mulgrew, CJ | 1 |
| Rudyk, O | 1 |
| Dutt, N | 1 |
| McLatchie, LM | 1 |
| Shattock, MJ | 1 |
| Hendry, BM | 1 |
| Hall-Craggs, M | 1 |
| Light, PD | 1 |
| Peters, RW | 1 |
| Barry, JM | 1 |
| Smith, CJ | 1 |
| Bolt, TR | 1 |
| Tareeva, IE | 1 |
| Kutyrina, IM | 1 |
| Galstian, GM | 1 |
| Rogov, VA | 1 |
| Brunner, FP | 1 |
| Thiel, G | 1 |
| Hermle, M | 1 |
| Bock, HA | 1 |
| Mihatsch, MJ | 1 |
1 review available for verapamil and Bright Disease
| Article | Year |
|---|---|
Management of the hypertensive patient: a case report.
Topics: Adult; Antihypertensive Agents; Blood Pressure Determination; Dental Care for Chronically Ill; Glome | 1995 |
1 trial available for verapamil and Bright Disease
| Article | Year |
|---|---|
[Calcium antagonists in the treatment of nephrogenic hypertension].
Topics: Adolescent; Adult; Calcium Channel Blockers; Glomerulonephritis; Hemodynamics; Humans; Hypertension, | 1990 |
3 other studies available for verapamil and Bright Disease
| Article | Year |
|---|---|
Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, T-Type; Creatinine; Dose-Respon | 2013 |
Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine.
Topics: Antigen-Antibody Complex; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney; Kidney | 1984 |
Long-term enalapril and verapamil in rats with reduced renal mass.
Topics: Animals; Enalapril; Female; Glomerulonephritis; Hypertension, Renal; Hypertrophy; Kidney; Nephrectom | 1989 |